首页 > 最新文献

Journal of Clinical Sleep Medicine最新文献

英文 中文
Impact of socioeconomic disparities on CPAP adherence. 社会经济差异对CPAP依从性的影响。
IF 2.9 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 DOI: 10.5664/jcsm.11874
Samuel R Shing, Nicole Molin, Jefferson DeKloe, Natalie M Perlov, Erin W Creighton, Maurits S Boon, Colin T Huntley, Ritu G Grewal

Study objectives: Socioeconomic disparities are known to have a significant impact on health outcomes including those related to obstructive sleep apnea. More recently, a metric known as area deprivation index (ADI), which combines 17 social determinants of health, has been used to better quantify this impact. We aim to examine the relationship between socioeconomic disparities and continuous positive airway pressure (CPAP) adherence among adults with obstructive sleep apnea using ADI.

Methods: A retrospective study of patients with diagnosis of obstructive sleep apnea and prescribed CPAP from October-December 2022 was performed. Patients were divided into more- or less-socioeconomically disadvantaged groups based on ADI, as well as social vulnerability index, which captures high school diploma rates. Thirty-day, 6-month, and 12-month CPAP adherence and follow-up rates were collected and compared across ADI/social vulnerability index quartiles.

Results: A total of 536 patients met inclusion criteria. Patients from the most deprived areas (highest ADI) had significantly lower CPAP adherence than those from least deprived areas at all timepoints (P < .05). Patients from areas with lower high school diploma rates had lower CPAP adherence (P < .05).

Conclusions: Socioeconomic disparities appear to have a significant impact on CPAP adherence. People from areas that are more deprived and with lower high school diploma rates have lower therapy adherence rates. Patients within these groups may benefit from additional resources and/or closer follow up to improve adherence with treatment.

Citation: Shing SR, Molin N, DeKloe J, et al. Impact of socioeconomic disparities on CPAP adherence. J Clin Sleep Med. 2025;21(12):2091-2099.

研究目的:众所周知,社会经济差异对健康结果有重大影响,包括与阻塞性睡眠呼吸暂停(OSA)相关的健康结果。最近,一种被称为“区域剥夺指数”(ADI)的指标(它结合了17个健康的社会决定因素)被用来更好地量化这种影响。我们的目的是研究社会经济差异与使用ADI的OSA成人患者持续气道正压通气(CPAP)依从性之间的关系。方法:对2022年10 - 12月诊断为OSA并给予CPAP治疗的患者进行回顾性研究。根据ADI和社会脆弱性指数(SVI)将患者分为社会经济弱势群体或弱势群体,SVI衡量的是高中毕业率。收集30天、6个月和12个月的CPAP依从性和随访率,并比较ADI/SVI四分位数。结果:536例患者符合纳入标准。在所有时间点上,来自最贫困地区(最高ADI)的患者的CPAP依从性明显低于来自最贫困地区的患者(ppp结论:社会经济差异似乎对CPAP依从性有显著影响。来自贫困地区和高中毕业率较低地区的人坚持治疗的比例较低。这些组中的患者可能受益于额外的资源和/或更密切的随访,以提高治疗的依从性。
{"title":"Impact of socioeconomic disparities on CPAP adherence.","authors":"Samuel R Shing, Nicole Molin, Jefferson DeKloe, Natalie M Perlov, Erin W Creighton, Maurits S Boon, Colin T Huntley, Ritu G Grewal","doi":"10.5664/jcsm.11874","DOIUrl":"10.5664/jcsm.11874","url":null,"abstract":"<p><strong>Study objectives: </strong>Socioeconomic disparities are known to have a significant impact on health outcomes including those related to obstructive sleep apnea. More recently, a metric known as area deprivation index (ADI), which combines 17 social determinants of health, has been used to better quantify this impact. We aim to examine the relationship between socioeconomic disparities and continuous positive airway pressure (CPAP) adherence among adults with obstructive sleep apnea using ADI.</p><p><strong>Methods: </strong>A retrospective study of patients with diagnosis of obstructive sleep apnea and prescribed CPAP from October-December 2022 was performed. Patients were divided into more- or less-socioeconomically disadvantaged groups based on ADI, as well as social vulnerability index, which captures high school diploma rates. Thirty-day, 6-month, and 12-month CPAP adherence and follow-up rates were collected and compared across ADI/social vulnerability index quartiles.</p><p><strong>Results: </strong>A total of 536 patients met inclusion criteria. Patients from the most deprived areas (highest ADI) had significantly lower CPAP adherence than those from least deprived areas at all timepoints (<i>P</i> < .05). Patients from areas with lower high school diploma rates had lower CPAP adherence (<i>P</i> < .05).</p><p><strong>Conclusions: </strong>Socioeconomic disparities appear to have a significant impact on CPAP adherence. People from areas that are more deprived and with lower high school diploma rates have lower therapy adherence rates. Patients within these groups may benefit from additional resources and/or closer follow up to improve adherence with treatment.</p><p><strong>Citation: </strong>Shing SR, Molin N, DeKloe J, et al. Impact of socioeconomic disparities on CPAP adherence. <i>J Clin Sleep Med</i>. 2025;21(12):2091-2099.</p>","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":"2091-2099"},"PeriodicalIF":2.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145082305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multisetting evaluation of Watch-PAT in obstructive sleep apnea diagnosis in patients with atrial fibrillation. Watch-PAT在房颤患者阻塞性睡眠呼吸暂停诊断中的多设定评价。
IF 2.9 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 DOI: 10.5664/jcsm.11898
Patrick L Stafford, Robert Roth, John Ferguson, Kenneth C Bilchick, Andrew E Darby, Sula Mazimba, Nishaki Mehta, Eric M Davis, Heather Bonner, Yeilim Cho, Jeongok Logan, Michelle Sobremonte-King, Younghoon Kwon

Study objectives: Patients with atrial fibrillation have elevated risk of obstructive sleep apnea (OSA). A peripheral arterial tonometry-based device, the Watch-PAT (WP) has been increasingly used as a home OSA test. We conducted a multisetting evaluation of WP in OSA diagnosis by comparing results from in-laboratory polysomnography (PSG), in-laboratory WP, and home WP in patients with atrial fibrillation.

Methods: Patients with atrial fibrillation underwent an in-laboratory PSG with concurrent in-laboratory WP and 2 consecutive nights of home WP. OSA was categorized into no OSA, mild, moderate, and severe OSA by apnea-hypopnea index (< 5, ≥ 5 to < 15, ≥ 15 to < 29, ≥ 30 events/h). The primary outcome was OSA severity agreement between in-laboratory PSG vs home WP. Secondary outcomes included the agreement between in-laboratory PSG vs in-laboratory WP, as well as in-laboratory WP vs home WP. Night-to-night variability of consecutive nights of home WP was also evaluated. Results were expressed by Cohen's kappa (κ) for apnea-hypopnea index scoring rules 1a and 1b.

Results: A total of 27 patients were included for analysis. There was slight and fair agreement between in-laboratory PSG and home WP (κ = 0.15, 0.40 for score rule 1a and 1b, respectively), substantial agreement between in-laboratory PSG vs in-laboratory WP (κ = 0.63, 0.71), moderate agreement between in-laboratory WP and home WP (κ = 0.59, 0.59), and almost perfect agreement between first night home WP and second night home WP (κ = 0.87, 0.89).

Conclusions: We demonstrate overall slight to fair agreement between home WP vs in-laboratory PSG, suggesting inadequate performance against the standard reference test. This should be considered when interpreting the results of home WP. Other evaluations demonstrated moderate agreement for in-laboratory WP and home WP in the classification of OSA severity, substantial agreement between in-laboratory PSG and in-laboratory WP, and almost perfect agreement in the comparison of both home WP.

Citation: Stafford PL, Roth R, Ferguson J, et al. Multisetting evaluation of Watch-PAT in obstructive sleep apnea diagnosis in patients with atrial fibrillation. J Clin Sleep Med. 2025;21(12):2139-2154.

研究目的:心房颤动(AF)患者发生阻塞性睡眠呼吸暂停(OSA)的风险增高。Watch-PAT (WP)是一种基于外周动脉血压计(PAT)的设备,已越来越多地用于家庭OSA测试。我们通过比较AF患者的实验室PSG、实验室WP和家庭WP的结果,对WP在OSA诊断中的多设置进行了评估。方法:房颤患者在实验室进行PSG,同时进行实验室WP和连续两晚的家庭WP。根据呼吸暂停低通气指数(AHI)将OSA分为无OSA、轻度、中度和重度OSA;结果:纳入27例患者进行分析。实验室内PSG和家庭WP之间有轻微和公平的一致性(κ=0.15,分别为评分规则1a和1b),实验室内PSG和实验室内WP之间有实质性的一致性(κ=0.63, 0.71),实验室内WP和家庭WP之间有中度一致性(κ=0.59, 0.59),第一晚在家WP和第二晚在家WP之间几乎完全一致(κ=0.87, 0.89)。结论:我们证明家庭WP与实验室PSG之间的总体一致性轻微到公平,表明与标准参考测试相比表现不佳。在解释家庭工作负荷的结果时应考虑到这一点。其他评估显示,实验室WP和家庭WP在OSA严重程度的分类上有中等程度的一致,实验室PSG和实验室WP之间有实质性的一致,在家庭WP的比较中几乎完全一致。
{"title":"Multisetting evaluation of Watch-PAT in obstructive sleep apnea diagnosis in patients with atrial fibrillation.","authors":"Patrick L Stafford, Robert Roth, John Ferguson, Kenneth C Bilchick, Andrew E Darby, Sula Mazimba, Nishaki Mehta, Eric M Davis, Heather Bonner, Yeilim Cho, Jeongok Logan, Michelle Sobremonte-King, Younghoon Kwon","doi":"10.5664/jcsm.11898","DOIUrl":"10.5664/jcsm.11898","url":null,"abstract":"<p><strong>Study objectives: </strong>Patients with atrial fibrillation have elevated risk of obstructive sleep apnea (OSA). A peripheral arterial tonometry-based device, the Watch-PAT (WP) has been increasingly used as a home OSA test. We conducted a multisetting evaluation of WP in OSA diagnosis by comparing results from in-laboratory polysomnography (PSG), in-laboratory WP, and home WP in patients with atrial fibrillation.</p><p><strong>Methods: </strong>Patients with atrial fibrillation underwent an in-laboratory PSG with concurrent in-laboratory WP and 2 consecutive nights of home WP. OSA was categorized into no OSA, mild, moderate, and severe OSA by apnea-hypopnea index (< 5, ≥ 5 to < 15, ≥ 15 to < 29, ≥ 30 events/h). The primary outcome was OSA severity agreement between in-laboratory PSG vs home WP. Secondary outcomes included the agreement between in-laboratory PSG vs in-laboratory WP, as well as in-laboratory WP vs home WP. Night-to-night variability of consecutive nights of home WP was also evaluated. Results were expressed by Cohen's kappa (κ) for apnea-hypopnea index scoring rules 1a and 1b.</p><p><strong>Results: </strong>A total of 27 patients were included for analysis. There was slight and fair agreement between in-laboratory PSG and home WP (κ = 0.15, 0.40 for score rule 1a and 1b, respectively), substantial agreement between in-laboratory PSG vs in-laboratory WP (κ = 0.63, 0.71), moderate agreement between in-laboratory WP and home WP (κ = 0.59, 0.59), and almost perfect agreement between first night home WP and second night home WP (κ = 0.87, 0.89).</p><p><strong>Conclusions: </strong>We demonstrate overall slight to fair agreement between home WP vs in-laboratory PSG, suggesting inadequate performance against the standard reference test. This should be considered when interpreting the results of home WP. Other evaluations demonstrated moderate agreement for in-laboratory WP and home WP in the classification of OSA severity, substantial agreement between in-laboratory PSG and in-laboratory WP, and almost perfect agreement in the comparison of both home WP.</p><p><strong>Citation: </strong>Stafford PL, Roth R, Ferguson J, et al. Multisetting evaluation of Watch-PAT in obstructive sleep apnea diagnosis in patients with atrial fibrillation. <i>J Clin Sleep Med</i>. 2025;21(12):2139-2154.</p>","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":"2139-2154"},"PeriodicalIF":2.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670615/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145214121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality measures for care of patients with restless legs syndrome: 2025 update after measure maintenance. 不宁腿综合征患者护理质量措施:2025年措施维持后的更新
IF 2.9 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 DOI: 10.5664/jcsm.11894
Robin M Lloyd, T'Auna Crawford, Ryan Donald, Diedra D Gray, William J Healy, Mithri R Junna, Daniel Lewin, Amee Revana, Sharon Schutte-Rodin

Restless legs syndrome, also called Willis-Ekbom disease, is a neurological disorder marked by a strong, uncontrollable urge to move the legs, often paired with unpleasant or uncomfortable sensations. To address gaps and variations in care in this patient population, the American Academy of Sleep Medicine Quality Measures Task Force performed quality measure maintenance on the quality measures for the care of adult patients with restless legs syndrome (originally developed in 2015). The Quality Measures Task Force conducted a comprehensive review of current medical literature, including updated clinical practice guidelines, systematic literature reviews, existing quality measures for restless legs syndrome, and performance data to identify ongoing gaps and variations in care since the implementation of the original quality measure set and to inform potential revisions.

Citation: Lloyd RM, Crawford T'A, Donald R, et al. Quality measures for care of patients with restless legs syndrome: 2025 update after measure maintenance. J Clin Sleep Med. 2025;21(12):2205-2211.

不宁腿综合征(RLS),也被称为威利斯-埃克博姆病,是一种神经系统疾病,其特征是强烈的,无法控制的移动腿部的冲动,通常伴随着不愉快或不舒服的感觉。为了解决这一患者群体在护理方面的差距和差异,美国睡眠医学学会(AASM)质量措施工作组(Task Force)对不宁腿综合征成年患者护理的质量措施进行了质量措施维护(最初于2015年开发)。工作组对目前的医学文献进行了全面的回顾,包括更新的临床实践指南、系统的文献回顾、不宁腿综合征的现有质量措施和表现数据,以确定自实施原始质量措施集以来在护理方面存在的差距和变化,并为可能的修订提供信息。
{"title":"Quality measures for care of patients with restless legs syndrome: 2025 update after measure maintenance.","authors":"Robin M Lloyd, T'Auna Crawford, Ryan Donald, Diedra D Gray, William J Healy, Mithri R Junna, Daniel Lewin, Amee Revana, Sharon Schutte-Rodin","doi":"10.5664/jcsm.11894","DOIUrl":"10.5664/jcsm.11894","url":null,"abstract":"<p><p>Restless legs syndrome, also called Willis-Ekbom disease, is a neurological disorder marked by a strong, uncontrollable urge to move the legs, often paired with unpleasant or uncomfortable sensations. To address gaps and variations in care in this patient population, the American Academy of Sleep Medicine Quality Measures Task Force performed quality measure maintenance on the quality measures for the care of adult patients with restless legs syndrome (originally developed in 2015). The Quality Measures Task Force conducted a comprehensive review of current medical literature, including updated clinical practice guidelines, systematic literature reviews, existing quality measures for restless legs syndrome, and performance data to identify ongoing gaps and variations in care since the implementation of the original quality measure set and to inform potential revisions.</p><p><strong>Citation: </strong>Lloyd RM, Crawford T'A, Donald R, et al. Quality measures for care of patients with restless legs syndrome: 2025 update after measure maintenance. <i>J Clin Sleep Med.</i> 2025;21(12):2205-2211.</p>","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":"2205-2211"},"PeriodicalIF":2.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of nurse-led, web-based brief behavioral therapy on insomnia severity in patients in the chronic stage of stroke recovery: a preliminary randomized controlled trial. 护士主导的基于网络的简短行为疗法对脑卒中慢性恢复期患者失眠严重程度的影响:一项初步随机对照试验。
IF 2.9 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 DOI: 10.5664/jcsm.11856
Faizul Hasan, Era Catur Prasetya, Christopher James Gordon, Debby Syahru Romadlon, Kai-Mei Chang, Delwyn J Bartlett, Chia-Jou Lin, Made Satya Nugraha Gautama, Nur Izzati, Hsiao-Yean Chiu

Study objectives: Insomnia is prevalent among stroke survivors in the chronic stage of stroke. However, effective interventions remain limited. This study examined the effects of nurse-led, face-to-face, and web-based brief behavioral therapy for insomnia (BBTI) compared with sleep hygiene education on sleep outcomes in stroke survivors.

Methods: A total of 45 stroke survivors were recruited from an outpatient clinic in Java, Indonesia, and randomly assigned (1:1:1) to either a face-to-face BBTI, web-based BBTI, or sleep hygiene education group. Both BBTI interventions followed a standardized 4-week protocol delivered in person or through an online platform. The primary outcome was insomnia severity, measured using the Indonesian version of the Insomnia Severity Index. Secondary outcomes included sleep onset latency, wake after sleep onset, sleep efficiency, excessive daytime sleepiness, anxiety, depression, and fatigue. Data were analyzed using generalized estimating equations.

Results: The Indonesian version of the Insomnia Severity Index scores were significantly lower in the BBTI groups than in the sleep hygiene education group. After 1 month, insomnia remission (Indonesian version of the Insomnia Severity Index score < 8) was achieved in 93.3% of the web-based BBTI group and 86.7% of the face-to-face BBTI group. These values were significantly higher than the 33.3% remission rate observed in the sleep hygiene education group (P < .001). Improvements were observed in sleep onset latency, wake after sleep onset, and sleep efficiency. The BBTI groups reported reduced daytime sleepiness, although no significant changes in depression, anxiety, or fatigue were observed.

Conclusions: Nurse-led BBTI, whether in the face-to-face or web-based format, effectively reduces insomnia severity and improves sleep outcomes in stroke survivors, highlighting nurses' essential role in delivering sleep interventions.

Clinical trial registration: Registry: ClinicalTrials.gov; Name: Nurse-led BBTI for Improving Insomnia Severity; URL: https://clinicaltrials.gov/study/NCT05310136; Identifier: NCT05310136.

Citation: Hasan F, Prasetya EC, Gordon CJ, et al. Effects of nurse-led, web-based brief behavioral therapy on insomnia severity in patients in the chronic stage of stroke recovery: a preliminary randomized controlled trial. J Clin Sleep Med. 2025;21(12):2031-2040.

研究目的:失眠在中风慢性期幸存者中普遍存在。然而,有效的干预措施仍然有限。本研究考察了护士主导、面对面和基于网络的失眠简短行为疗法(BBTI)与睡眠卫生教育(SHE)对中风幸存者睡眠结果的影响。方法:从印度尼西亚爪哇的一家门诊诊所招募了45名中风幸存者,并随机分配(1:1:1)到面对面的BBTI组、基于网络的BBTI组或SHE组。两种BBTI干预都遵循一个标准化的为期4周的协议,该协议由亲自或通过在线平台交付。主要终点是失眠严重程度,用印尼失眠严重程度指数(ISI-INA)测量。次要结局包括睡眠开始潜伏期、睡眠开始后醒来、睡眠效率、白天过度嗜睡、焦虑、抑郁和疲劳。采用广义估计方程对数据进行分析。结果:BBTI组ISI-INA评分明显低于SHE组。1个月后,93.3%的网络BBTI组失眠缓解(ISI-INA评分< 8),86.7%的面对面BBTI组失眠缓解。这些数值明显高于SHE组33.3%的缓解率(P < 0.001)。在睡眠开始潜伏期、睡眠开始后醒来和睡眠效率方面观察到改善。BBTI组报告白天嗜睡减少,但没有观察到抑郁、焦虑或疲劳的显著变化。结论:护士主导的BBTI,无论是面对面还是基于网络的形式,都能有效降低中风幸存者的失眠严重程度,改善睡眠结果,突出了护士在提供睡眠干预方面的重要作用。临床试验注册:注册:ClinicalTrials.gov;标识符:NCT05310136。
{"title":"Effects of nurse-led, web-based brief behavioral therapy on insomnia severity in patients in the chronic stage of stroke recovery: a preliminary randomized controlled trial.","authors":"Faizul Hasan, Era Catur Prasetya, Christopher James Gordon, Debby Syahru Romadlon, Kai-Mei Chang, Delwyn J Bartlett, Chia-Jou Lin, Made Satya Nugraha Gautama, Nur Izzati, Hsiao-Yean Chiu","doi":"10.5664/jcsm.11856","DOIUrl":"10.5664/jcsm.11856","url":null,"abstract":"<p><strong>Study objectives: </strong>Insomnia is prevalent among stroke survivors in the chronic stage of stroke. However, effective interventions remain limited. This study examined the effects of nurse-led, face-to-face, and web-based brief behavioral therapy for insomnia (BBTI) compared with sleep hygiene education on sleep outcomes in stroke survivors.</p><p><strong>Methods: </strong>A total of 45 stroke survivors were recruited from an outpatient clinic in Java, Indonesia, and randomly assigned (1:1:1) to either a face-to-face BBTI, web-based BBTI, or sleep hygiene education group. Both BBTI interventions followed a standardized 4-week protocol delivered in person or through an online platform. The primary outcome was insomnia severity, measured using the Indonesian version of the Insomnia Severity Index. Secondary outcomes included sleep onset latency, wake after sleep onset, sleep efficiency, excessive daytime sleepiness, anxiety, depression, and fatigue. Data were analyzed using generalized estimating equations.</p><p><strong>Results: </strong>The Indonesian version of the Insomnia Severity Index scores were significantly lower in the BBTI groups than in the sleep hygiene education group. After 1 month, insomnia remission (Indonesian version of the Insomnia Severity Index score < 8) was achieved in 93.3% of the web-based BBTI group and 86.7% of the face-to-face BBTI group. These values were significantly higher than the 33.3% remission rate observed in the sleep hygiene education group (<i>P</i> < .001). Improvements were observed in sleep onset latency, wake after sleep onset, and sleep efficiency. The BBTI groups reported reduced daytime sleepiness, although no significant changes in depression, anxiety, or fatigue were observed.</p><p><strong>Conclusions: </strong>Nurse-led BBTI, whether in the face-to-face or web-based format, effectively reduces insomnia severity and improves sleep outcomes in stroke survivors, highlighting nurses' essential role in delivering sleep interventions.</p><p><strong>Clinical trial registration: </strong>Registry: ClinicalTrials.gov; Name: Nurse-led BBTI for Improving Insomnia Severity; URL: https://clinicaltrials.gov/study/NCT05310136; Identifier: NCT05310136.</p><p><strong>Citation: </strong>Hasan F, Prasetya EC, Gordon CJ, et al. Effects of nurse-led, web-based brief behavioral therapy on insomnia severity in patients in the chronic stage of stroke recovery: a preliminary randomized controlled trial. <i>J Clin Sleep Med</i>. 2025;21(12):2031-2040.</p>","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":"2031-2040"},"PeriodicalIF":2.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670614/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144994192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autonomic responses to respiratory events and risk of chronic kidney disease in obstructive sleep apnea. 阻塞性睡眠呼吸暂停患者对呼吸事件的自主神经反应和慢性肾脏疾病的风险
IF 2.9 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 DOI: 10.5664/jcsm.11852
Mohammadreza Hajipour, Andrew E Beaudin, Joshua B Hicks, Ali Abdul Ghafoor, Jill K Raneri, A J Hirsch Allen, Zahra Izadi, Rachel Jen, Tetyana Kendzerska, Fréderic Series, Robert P Skomro, Rebecca Robillard, R John Kimoff, Sidney Fels, Amrit Singh, Sofia B Ahmed, Ali Azarbarzin, Najib T Ayas, Patrick J Hanly

Study objectives: Obstructive sleep apnea-related hypoxemia, measured by hypoxic burden (HB), is associated with chronic kidney disease (CKD). Obstructive sleep apnea-related autonomic response may also be associated with CKD. This study examined whether individuals with high HB and varying autonomic responses to obstructive sleep apnea have a different risk of CKD progression compared to those with low HB.

Methods: Polysomnography data from the multicenter Canadian Sleep and Circadian Network cohort were analyzed. HB was defined as the area under event-related oxygen desaturation curves during sleep. Autonomic responses were assessed using "vasoconstriction burden" (area under photoplethysmography declines, reflecting vascular reactivity) and heart rate response to events (reflecting cardiac autonomic response). Estimated glomerular filtration rate and urine albumin:creatinine ratio were used to identify participants at risk of CKD progression. This risk was compared across individuals with high HB (≥ median) and varying levels of autonomic responses relative to those with low HB.

Results: Data from 421 participants were analyzed. The odds ratio of CKD progression was higher in those with high vs low HB. Compared to the low HB group, individuals with high HB and low vasoconstriction burden (lowest quartile) were at increased risk of CKD progression (odds ratio [95% confidence interval] = 2.49 [1.23, 5.05]), whereas the risk was not significantly elevated in those with the high vasoconstriction burden (highest quartile). In contrast, within high HB, both high (highest quartile) and low heart rate response (lowest quartile) groups were at increased risk of CKD progression compared to those with low HB.

Conclusions: Autonomic response to respiratory events improves risk stratification for CKD progression in obstructive sleep apnea. Vasoconstriction burden and heart rate response show distinct associations with this risk.

Citation: Hajipour M, Beaudin AE, Hicks JB, et al. Autonomic responses to respiratory events and risk of chronic kidney disease in obstructive sleep apnea. J Clin Sleep Med. 2025;21(12):2041-2050.

研究目的:阻塞性睡眠呼吸暂停(OSA)相关的低氧血症,通过低氧负荷(HB)来测量,与慢性肾脏疾病(CKD)相关。asa相关的自主神经反应也可能与CKD有关。本研究考察了与低HB患者相比,高HB患者和不同的OSA自主神经反应是否具有不同的CKD进展风险。方法:对来自多中心加拿大睡眠和昼夜节律网络队列的多导睡眠图数据进行分析。HB定义为睡眠时事件相关血氧去饱和曲线下的面积。自主神经反应通过“血管收缩负荷”(VCB:光容积脉搏图下面积下降,反映血管反应性)和对事件的心率反应(ΔHR,反映心脏自主神经反应)来评估。估计肾小球滤过率和尿白蛋白:肌酐比值被用来识别有CKD进展风险的参与者。比较了高血红蛋白(≥中位数)个体和相对于低血红蛋白个体不同水平的自主神经反应的风险。结果:分析了421名参与者的数据。与低HB相比,高HB患者CKD进展的几率更高。与低HB组相比,高HB和低VCB的个体(最低四分位数)CKD进展的风险增加(优势比[95% CI] = 2.49[1.23,5.05]),而高VCB的个体(最高四分位数)的风险没有显著升高。相比之下,在高HB组中,与低HB组相比,高(最高四分位数)和低ΔHR(最低四分位数)组CKD进展的风险都增加。结论:呼吸事件的自主反应改善了OSA患者CKD进展的风险分层。VCB和ΔHR与这种风险有明显关联。
{"title":"Autonomic responses to respiratory events and risk of chronic kidney disease in obstructive sleep apnea.","authors":"Mohammadreza Hajipour, Andrew E Beaudin, Joshua B Hicks, Ali Abdul Ghafoor, Jill K Raneri, A J Hirsch Allen, Zahra Izadi, Rachel Jen, Tetyana Kendzerska, Fréderic Series, Robert P Skomro, Rebecca Robillard, R John Kimoff, Sidney Fels, Amrit Singh, Sofia B Ahmed, Ali Azarbarzin, Najib T Ayas, Patrick J Hanly","doi":"10.5664/jcsm.11852","DOIUrl":"10.5664/jcsm.11852","url":null,"abstract":"<p><strong>Study objectives: </strong>Obstructive sleep apnea-related hypoxemia, measured by hypoxic burden (HB), is associated with chronic kidney disease (CKD). Obstructive sleep apnea-related autonomic response may also be associated with CKD. This study examined whether individuals with high HB and varying autonomic responses to obstructive sleep apnea have a different risk of CKD progression compared to those with low HB.</p><p><strong>Methods: </strong>Polysomnography data from the multicenter Canadian Sleep and Circadian Network cohort were analyzed. HB was defined as the area under event-related oxygen desaturation curves during sleep. Autonomic responses were assessed using \"vasoconstriction burden\" (area under photoplethysmography declines, reflecting vascular reactivity) and heart rate response to events (reflecting cardiac autonomic response). Estimated glomerular filtration rate and urine albumin:creatinine ratio were used to identify participants at risk of CKD progression. This risk was compared across individuals with high HB (≥ median) and varying levels of autonomic responses relative to those with low HB.</p><p><strong>Results: </strong>Data from 421 participants were analyzed. The odds ratio of CKD progression was higher in those with high vs low HB. Compared to the low HB group, individuals with high HB and low vasoconstriction burden (lowest quartile) were at increased risk of CKD progression (odds ratio [95% confidence interval] = 2.49 [1.23, 5.05]), whereas the risk was not significantly elevated in those with the high vasoconstriction burden (highest quartile). In contrast, within high HB, both high (highest quartile) and low heart rate response (lowest quartile) groups were at increased risk of CKD progression compared to those with low HB.</p><p><strong>Conclusions: </strong>Autonomic response to respiratory events improves risk stratification for CKD progression in obstructive sleep apnea. Vasoconstriction burden and heart rate response show distinct associations with this risk.</p><p><strong>Citation: </strong>Hajipour M, Beaudin AE, Hicks JB, et al. Autonomic responses to respiratory events and risk of chronic kidney disease in obstructive sleep apnea. <i>J Clin Sleep Med</i>. 2025;21(12):2041-2050.</p>","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":"2041-2050"},"PeriodicalIF":2.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670612/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144977282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A double-blind, randomized, placebo-controlled trial of doxazosin for posttraumatic distressing dreams and sleep disturbance in men and women with posttraumatic stress. 一项双盲、随机、安慰剂对照试验:多沙唑嗪治疗创伤后应激障碍患者的创伤后痛苦梦和睡眠障碍。
IF 2.9 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 DOI: 10.5664/jcsm.11908
Anne Richards, Anthony C Santistevan, Leslie M Yack, Anna C West, Emily Berg, Shane Pracar, Steven L Batki, Karen H Seal, Thomas C Neylan
<p><strong>Study objectives: </strong>Distressing dreams and sleep disturbance more broadly are core features of posttraumatic stress disorder. Effective treatments remain elusive. Doxazosin is an alpha-1 adrenergic blocker with demonstrated promise for posttraumatic stress disorder, but there is a dearth of evidence from randomized controlled trials. The current randomized, double-blind, placebo-controlled trial evaluated the effectiveness of doxazosin for distressing dreams and sleep disturbances in adult men and women with trauma history and prominent distressing dreams.</p><p><strong>Methods: </strong>Trauma-exposed adults (n = 65; 60 veterans, 21 female) with full or subclinical posttraumatic stress disorder and prominent nightmares were randomly assigned to either placebo (n = 32) or doxazosin immediate-release (n = 33) titrated to a maximum dose of 10 mg daily. Prespecified primary outcomes were distressing dream frequency and intensity (Clinician-Administered PTSD Scale-IV) and sleep quality (Pittsburg Sleep Quality Index). Prespecified secondary outcomes were distressing dream frequency, worst distressing dream severity, and properties of sleep (sleep latency, wake after sleep onset, sleep maintenance, and total sleep time) measured daily using a sleep diary mobile application.</p><p><strong>Results: </strong>Compared to placebo, Clinician-Administered PTSD Scale-IV nightmare and Pittsburg Sleep Quality Index sleep quality outcomes did not differ significantly over the course of the trial between treatment groups (adjusted <i>Ps</i> > .05), in part due to robust placebo effects in these measures. In contrast, participants randomly assigned to doxazosin showed a greater increase in sleep maintenance (adjusted <i>P</i> = .047) and greater reduction in worst distressing dream severity (adjusted <i>P</i> < .001) over the course of the trial as measured by a daily sleep diary. These effects predominated in males and were moderated by baseline standing orthostatic systolic blood pressure.</p><p><strong>Conclusions: </strong>Doxazosin demonstrated statistically significant, clinically modest effects on prespecified sleep diary measures of distressing dream and sleep outcomes relative to placebo, but no effects based on clinical interview and survey measures. Ongoing research is therefore critical to improve treatment options for both males and females, for whom treatment benefits may differ, and to improve measurement in distressing dreams research so as to further develop targeted and effective treatment solutions.</p><p><strong>Clinical trial registration: </strong>Registry: ClinicalTrials.gov; Name: A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD; URL: https://clinicaltrials.gov/study/NCT03339258; Identifier: NCT03339258.</p><p><strong>Citation: </strong>Richards A, Santistevan AC, Yack LM, et al. A double-blind, randomized, placebo-controlled trial of doxazosin for po
研究目的:痛苦的梦和更广泛的睡眠障碍是创伤后应激障碍的核心特征。有效的治疗方法仍然难以捉摸。Doxazosin是一种α -1肾上腺素能阻滞剂,被证明有治疗PTSD的希望,但缺乏随机对照试验的证据。目前的随机、双盲、安慰剂对照试验评估了doxazosin对有创伤史和突出的痛苦梦的成年男女的痛苦梦和睡眠障碍的有效性。方法:65名创伤暴露的成人(60名退伍军人,21名女性),患有完全或亚临床创伤后应激障碍和突出的噩梦,随机分为安慰剂组(N=32)和多沙唑嗪组(N= 33),最大剂量为每日10 mg。预先指定的主要结局是痛苦梦的频率和强度(CAPS-IV)和睡眠质量(PSQI)。预先指定的次要结果是每天使用睡眠日记移动应用程序测量的痛苦梦频率、最糟糕的痛苦梦严重程度和睡眠特性(睡眠潜伏期、睡眠发作后醒来、睡眠维持和总睡眠时间)。结果:与安慰剂相比,CAPS-IV噩梦和PSQI睡眠质量结果在治疗组之间的试验过程中没有显着差异(调整p < 0.05),部分原因是这些措施中的安慰剂效应很强。相比之下,随机分配到doxazosin的参与者在试验过程中显示出更大的睡眠维持(调整p = 0.047)和更大的减少最糟糕的痛苦梦的严重程度(调整p < 0.001),这是通过每日睡眠日记来测量的。这些影响在男性中占主导地位,并被基线站立站立收缩压所缓和。结论:与安慰剂相比,Doxazosin在预先设定的睡眠日记测量的痛苦梦和睡眠结果方面表现出统计学上显著的临床适度效果,但根据临床访谈和调查测量没有效果。因此,正在进行的研究对于改善男性和女性的治疗选择至关重要,因为治疗效果可能不同,并且改善痛苦梦研究的测量,从而进一步开发有针对性和有效的治疗方案。临床试验注册:注册:ClinicalTrials.gov;多沙唑嗪治疗PTSD患者噩梦、睡眠障碍和非噩梦临床症状的随机对照试验标识符:NCT03339258;URL: https://clinicaltrials.gov/study/NCT03339258。
{"title":"A double-blind, randomized, placebo-controlled trial of doxazosin for posttraumatic distressing dreams and sleep disturbance in men and women with posttraumatic stress.","authors":"Anne Richards, Anthony C Santistevan, Leslie M Yack, Anna C West, Emily Berg, Shane Pracar, Steven L Batki, Karen H Seal, Thomas C Neylan","doi":"10.5664/jcsm.11908","DOIUrl":"10.5664/jcsm.11908","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Study objectives: &lt;/strong&gt;Distressing dreams and sleep disturbance more broadly are core features of posttraumatic stress disorder. Effective treatments remain elusive. Doxazosin is an alpha-1 adrenergic blocker with demonstrated promise for posttraumatic stress disorder, but there is a dearth of evidence from randomized controlled trials. The current randomized, double-blind, placebo-controlled trial evaluated the effectiveness of doxazosin for distressing dreams and sleep disturbances in adult men and women with trauma history and prominent distressing dreams.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Trauma-exposed adults (n = 65; 60 veterans, 21 female) with full or subclinical posttraumatic stress disorder and prominent nightmares were randomly assigned to either placebo (n = 32) or doxazosin immediate-release (n = 33) titrated to a maximum dose of 10 mg daily. Prespecified primary outcomes were distressing dream frequency and intensity (Clinician-Administered PTSD Scale-IV) and sleep quality (Pittsburg Sleep Quality Index). Prespecified secondary outcomes were distressing dream frequency, worst distressing dream severity, and properties of sleep (sleep latency, wake after sleep onset, sleep maintenance, and total sleep time) measured daily using a sleep diary mobile application.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Compared to placebo, Clinician-Administered PTSD Scale-IV nightmare and Pittsburg Sleep Quality Index sleep quality outcomes did not differ significantly over the course of the trial between treatment groups (adjusted &lt;i&gt;Ps&lt;/i&gt; &gt; .05), in part due to robust placebo effects in these measures. In contrast, participants randomly assigned to doxazosin showed a greater increase in sleep maintenance (adjusted &lt;i&gt;P&lt;/i&gt; = .047) and greater reduction in worst distressing dream severity (adjusted &lt;i&gt;P&lt;/i&gt; &lt; .001) over the course of the trial as measured by a daily sleep diary. These effects predominated in males and were moderated by baseline standing orthostatic systolic blood pressure.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Doxazosin demonstrated statistically significant, clinically modest effects on prespecified sleep diary measures of distressing dream and sleep outcomes relative to placebo, but no effects based on clinical interview and survey measures. Ongoing research is therefore critical to improve treatment options for both males and females, for whom treatment benefits may differ, and to improve measurement in distressing dreams research so as to further develop targeted and effective treatment solutions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Clinical trial registration: &lt;/strong&gt;Registry: ClinicalTrials.gov; Name: A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD; URL: https://clinicaltrials.gov/study/NCT03339258; Identifier: NCT03339258.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Citation: &lt;/strong&gt;Richards A, Santistevan AC, Yack LM, et al. A double-blind, randomized, placebo-controlled trial of doxazosin for po","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":"2165-2179"},"PeriodicalIF":2.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670624/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145213857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does opioid-related central sleep apnea independently cause increased daytime sleepiness? 阿片类药物相关的中枢性睡眠呼吸暂停是否独立导致白天嗜睡增加?
IF 2.9 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 DOI: 10.5664/jcsm.11878
David Wang, Brendon J Yee, Frances Chung
{"title":"Does opioid-related central sleep apnea independently cause increased daytime sleepiness?","authors":"David Wang, Brendon J Yee, Frances Chung","doi":"10.5664/jcsm.11878","DOIUrl":"10.5664/jcsm.11878","url":null,"abstract":"","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":"2263"},"PeriodicalIF":2.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144994208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prodromal features and risk of neurodegenerative disorders diagnosis in outpatients with REM sleep behavior disorder. 快速眼动睡眠行为障碍门诊患者神经退行性疾病的前驱特征及诊断风险
IF 2.9 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-11-01 DOI: 10.5664/jcsm.11824
Lana M Chahine, Anne Newman, Richard D Boyce, Maria M Brooks

Study objectives: Individuals with isolated rapid eye movement sleep behavior disorder (iRBD) are at high risk of neurodegenerative parkinsonian disorders or dementia (NPD). Determining which characteristics predict greatest risk could improve clinical care. Our objectives were to utilize electronic health record data to apply prodromal Parkinson's disease research diagnostic criteria to outpatients with iRBD and determine their utility for identifying patients with iRBD at high vs low risk for NPD diagnosis.

Methods: This was a retrospective cohort study at a tertiary care center in western Pennsylvania. Diagnosis of iRBD was confirmed with expert manual chart review. Prodromal risk markers and signs and symptoms were determined with diagnostic codes. Multivariable Cox proportional hazards models examined a range of covariates as predictors of time to NPD diagnosis.

Results: Of 448 patients with iRBD, 82 (18.30%) were diagnosed with NPD. Forty-nine (10.93%) had > 80% prodromal Parkinson's disease probability. There was no difference in time to NPD among those who met vs did not meet > 80% probability (log-rank P = .49). In a Cox model that included all assessed criteria features, risk of diagnosis was associated with male sex (hazard ratio = 2.06, 95% confidence interval = 1.04-1.10), older baseline age (hazard ratio = 1.07, 95% confidence interval = 1.05-1.10), and cognitive dysfunction diagnostic code (hazard ratio = 2.83, 95% confidence interval = 1.79-4.46). Time to NPD diagnosis among patients with predicted high vs low risk was significantly different (log-rank test P = .012).

Conclusions: In outpatients with iRBD, a model combining individual Parkinson's disease risk factors and prodromal features accurately identifies individuals at high risk for NPD diagnosis. Results demonstrate the potential of electronic health record data to translate research on prodromal Parkinson's disease to the clinic.

Citation: Chahine LM, Newman A, Boyce RD, Brooks MM. Prodromal features and risk of neurodegenerative disorders diagnosis in outpatients with REM sleep behavior disorder. J Clin Sleep Med. 2025;21(11):1857-1869.

研究目的:孤立的快速眼动睡眠行为障碍(iRBD)个体具有神经退行性帕金森病或痴呆(NPD)的高风险。确定哪些特征预示着最大的风险可以改善临床护理。我们的目标是利用电子健康记录(EHR)数据将前驱PD研究诊断标准应用于iRBD门诊患者,并确定其在识别高风险和低风险iRBD病例中用于NPD诊断的实用性。方法:这是一项在宾夕法尼亚州西部三级保健中心进行的回顾性队列研究。通过专家手工图表检查确认iRBD的诊断。用诊断代码确定前驱风险标记物和体征/症状。多变量Cox比例风险模型检验了一系列协变量作为NPD诊断时间的预测因子。结果:在448例iRBD中,82例(18.30%)被诊断为NPD。49例(10.93%)PD前驱概率为80%。在达到目标与未达到目标的人群中,达到目标的时间没有差异,概率为80% (log rank p=0.49)。在包含所有评估标准特征的Cox模型中,诊断风险与男性(HR=2.06, 95%CI 1.04-1.10)、较大的基线年龄(HR=1.07;95%CI 1.05-1.10)和认知功能障碍诊断代码(HR= 2.83, 95%CI 1.79-4.46)。预测的高、低危险病例到NPD诊断的时间有显著差异(Log-rank检验p=0.012)。结论:在iRBD门诊患者中,结合个体PD危险因素和前驱特征的模型可以准确识别出NPD诊断的高风险个体。结果表明,电子病历数据有潜力将前驱帕金森病的研究转化为临床。
{"title":"Prodromal features and risk of neurodegenerative disorders diagnosis in outpatients with REM sleep behavior disorder.","authors":"Lana M Chahine, Anne Newman, Richard D Boyce, Maria M Brooks","doi":"10.5664/jcsm.11824","DOIUrl":"10.5664/jcsm.11824","url":null,"abstract":"<p><strong>Study objectives: </strong>Individuals with isolated rapid eye movement sleep behavior disorder (iRBD) are at high risk of neurodegenerative parkinsonian disorders or dementia (NPD). Determining which characteristics predict greatest risk could improve clinical care. Our objectives were to utilize electronic health record data to apply prodromal Parkinson's disease research diagnostic criteria to outpatients with iRBD and determine their utility for identifying patients with iRBD at high vs low risk for NPD diagnosis.</p><p><strong>Methods: </strong>This was a retrospective cohort study at a tertiary care center in western Pennsylvania. Diagnosis of iRBD was confirmed with expert manual chart review. Prodromal risk markers and signs and symptoms were determined with diagnostic codes. Multivariable Cox proportional hazards models examined a range of covariates as predictors of time to NPD diagnosis.</p><p><strong>Results: </strong>Of 448 patients with iRBD, 82 (18.30%) were diagnosed with NPD. Forty-nine (10.93%) had > 80% prodromal Parkinson's disease probability. There was no difference in time to NPD among those who met vs did not meet > 80% probability (log-rank <i>P</i> = .49). In a Cox model that included all assessed criteria features, risk of diagnosis was associated with male sex (hazard ratio = 2.06, 95% confidence interval = 1.04-1.10), older baseline age (hazard ratio = 1.07, 95% confidence interval = 1.05-1.10), and cognitive dysfunction diagnostic code (hazard ratio = 2.83, 95% confidence interval = 1.79-4.46). Time to NPD diagnosis among patients with predicted high vs low risk was significantly different (log-rank test <i>P</i> = .012).</p><p><strong>Conclusions: </strong>In outpatients with iRBD, a model combining individual Parkinson's disease risk factors and prodromal features accurately identifies individuals at high risk for NPD diagnosis. Results demonstrate the potential of electronic health record data to translate research on prodromal Parkinson's disease to the clinic.</p><p><strong>Citation: </strong>Chahine LM, Newman A, Boyce RD, Brooks MM. Prodromal features and risk of neurodegenerative disorders diagnosis in outpatients with REM sleep behavior disorder. <i>J Clin Sleep Med</i>. 2025;21(11):1857-1869.</p>","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":"1857-1869"},"PeriodicalIF":2.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12582213/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144755035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symptomatic opioid users are more likely to have greater improvements in sleepiness and quality of life with adaptive servo-ventilation treatment. 有症状的阿片类药物使用者更有可能通过适应性伺服通气治疗在嗜睡和生活质量方面有更大的改善。
IF 2.9 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-11-01 DOI: 10.5664/jcsm.11836
Jean-Louis Pepin, Adam V Benjafield, Michael Arzt
{"title":"Symptomatic opioid users are more likely to have greater improvements in sleepiness and quality of life with adaptive servo-ventilation treatment.","authors":"Jean-Louis Pepin, Adam V Benjafield, Michael Arzt","doi":"10.5664/jcsm.11836","DOIUrl":"10.5664/jcsm.11836","url":null,"abstract":"","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":"2009"},"PeriodicalIF":2.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12582203/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144776710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modified uvulopalatopharyngoplasty in modern obstructive sleep apnea treatment: a narrative review. 改良悬雍垂腭咽成形术在现代阻塞性睡眠呼吸暂停治疗中的应用综述。
IF 2.9 3区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-11-01 DOI: 10.5664/jcsm.11810
Thomas M Kaffenberger, Ryan J Soose, B Tucker Woodson, Stuart G MacKay, Edward M Weaver, Charles W Atwood, Patrick J Strollo

Study objectives: Obstructive sleep apnea is a prevalent disorder associated with significant health risks, often managed with continuous positive airway pressure. However, continuous positive airway pressure adherence remains suboptimal, prompting interest in surgical alternatives. Traditional uvulopalatopharyngoplasty (UPPP), introduced in 1981, has demonstrated limited success and notable side effects, leading to skepticism regarding its utility in obstructive sleep apnea treatment. However, advancements in patient selection and surgical technique have led to the development of modified UPPP procedures, including expansion sphincter pharyngoplasty, barbed reposition pharyngoplasty, and the Australian modified UPPP.

Methods: In this narrative review, we focus on the evolution of the palatal surgery field over the past 2 decades.

Results: Recent randomized controlled trials and observational cohort studies have shown that modified UPPP variants can significantly reduce apnea-hypopnea index, improve symptoms, and even offer potential cardiovascular benefits. These reconstructive approaches have demonstrated consistently improved success rates, enhanced patient-reported outcomes, and reduced postoperative morbidity compared to traditional excisional UPPP.

Conclusions: While controversies persist regarding patient selection, long-term durability, and the role of palate surgery in the era of hypoglossal nerve stimulation, emerging evidence supports modified UPPP as a viable alternative for appropriately selected patients with obstructive sleep apnea. This review underscores the evolution of palatal surgery, highlighting its role in a personalized, multimodal approach to obstructive sleep apnea management, particularly for continuous positive airway pressure-intolerant patients seeking durable and effective treatment.

Citation: Kaffenberger TM, Soose RJ, Woodson BT, et al. Modified uvulopalatopharyngoplasty in modern obstructive sleep apnea treatment: a narrative review. J Clin Sleep Med. 2025;21(11):1979-1991.

研究目的:阻塞性睡眠呼吸暂停(OSA)是一种与重大健康风险相关的普遍疾病,通常通过持续气道正压通气(CPAP)进行治疗。然而,CPAP的依从性仍然不是最佳的,这促使人们对手术替代方案产生了兴趣。传统的悬雍垂腭咽成形术(UPPP)于1981年推出,其成功程度有限,副作用显著,导致人们对其在OSA治疗中的应用持怀疑态度。然而,患者选择和手术技术的进步导致了改良的UPPP手术的发展,包括扩张括约肌咽成形术、倒钩复位咽成形术和澳大利亚改良的UPPP。方法:本文回顾了近二十年来腭外科领域的发展。结果:最近的随机对照试验和观察性队列研究表明,改良后的UPPP变体可以显著降低呼吸暂停低通气指数(AHI),改善症状,甚至提供潜在的心血管益处。与传统的upppp切除术相比,这些重建方法已经证明了持续提高的成功率,增强了患者报告的结果,并降低了术后发病率。结论:尽管关于患者选择、长期持久性以及腭裂手术在舌下神经刺激时代的作用存在争议,但新出现的证据支持改良的UPPP作为适当选择OSA患者的可行选择。这篇综述强调了腭外科手术的发展,强调了其在OSA管理的个性化、多模式方法中的作用,特别是对于寻求持久有效治疗的cpap不耐受患者。
{"title":"Modified uvulopalatopharyngoplasty in modern obstructive sleep apnea treatment: a narrative review.","authors":"Thomas M Kaffenberger, Ryan J Soose, B Tucker Woodson, Stuart G MacKay, Edward M Weaver, Charles W Atwood, Patrick J Strollo","doi":"10.5664/jcsm.11810","DOIUrl":"10.5664/jcsm.11810","url":null,"abstract":"<p><strong>Study objectives: </strong>Obstructive sleep apnea is a prevalent disorder associated with significant health risks, often managed with continuous positive airway pressure. However, continuous positive airway pressure adherence remains suboptimal, prompting interest in surgical alternatives. Traditional uvulopalatopharyngoplasty (UPPP), introduced in 1981, has demonstrated limited success and notable side effects, leading to skepticism regarding its utility in obstructive sleep apnea treatment. However, advancements in patient selection and surgical technique have led to the development of modified UPPP procedures, including expansion sphincter pharyngoplasty, barbed reposition pharyngoplasty, and the Australian modified UPPP.</p><p><strong>Methods: </strong>In this narrative review, we focus on the evolution of the palatal surgery field over the past 2 decades.</p><p><strong>Results: </strong>Recent randomized controlled trials and observational cohort studies have shown that modified UPPP variants can significantly reduce apnea-hypopnea index, improve symptoms, and even offer potential cardiovascular benefits. These reconstructive approaches have demonstrated consistently improved success rates, enhanced patient-reported outcomes, and reduced postoperative morbidity compared to traditional excisional UPPP.</p><p><strong>Conclusions: </strong>While controversies persist regarding patient selection, long-term durability, and the role of palate surgery in the era of hypoglossal nerve stimulation, emerging evidence supports modified UPPP as a viable alternative for appropriately selected patients with obstructive sleep apnea. This review underscores the evolution of palatal surgery, highlighting its role in a personalized, multimodal approach to obstructive sleep apnea management, particularly for continuous positive airway pressure-intolerant patients seeking durable and effective treatment.</p><p><strong>Citation: </strong>Kaffenberger TM, Soose RJ, Woodson BT, et al. Modified uvulopalatopharyngoplasty in modern obstructive sleep apnea treatment: a narrative review. <i>J Clin Sleep Med</i>. 2025;21(11):1979-1991.</p>","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":"1979-1991"},"PeriodicalIF":2.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12582202/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144610238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Sleep Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1